• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Chief Executive Officer Depasquale Michael W bought $3,900 worth of shares (5,000 units at $0.78), increasing direct ownership by 10% to 53,519 units (SEC Form 4)

    6/16/25 8:19:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    DEPASQUALE MICHAEL W

    (Last) (First) (Middle)
    C/O BIO-KEY INTERNATIONAL, INC.
    101 CRAWFORDS CORNER RD, SUITE 4116

    (Street)
    HOLMDEL NJ 07733

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    BIO KEY INTERNATIONAL INC [ BKYI ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    X Officer (give title below) X Other (specify below)
    Chief Executive Officer Chairman
    3. Date of Earliest Transaction (Month/Day/Year)
    06/13/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 06/13/2025 P V 5,000 A $0.78 53,519(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants.
    /s/ Michael DePasquale 06/16/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $BKYI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    SEC Filings

    See more
    • BIO-key International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits

      8-K - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:46:01 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 10-Q filed by BIO-key International Inc.

      10-Q - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/15/25 4:31:41 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 424B3 filed by BIO-key International Inc.

      424B3 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

      5/12/25 4:31:59 PM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Leadership Updates

    Live Leadership Updates

    See more
    • BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

      DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien

      12/11/23 7:59:02 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Software Provider BIO-key Names Seasoned Financial Services Executive Cameron E. Williams to its Board of Directors

      WALL, N.J., June 02, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring Identity-Bound Biometrics (IBB), today announced that it has appointed Cameron E. Williams to its Board of Directors. Mr. Williams has spent over forty years in leading executive officer roles in banking and financial services firms, serving on the board of directors of multiple organizations and more recently, in founding and leading strategic, financial and security consulting firms. Mr. Williams brings deep experience, an ideal skill set, and a broad base of relationships to his role on BIO-key

      6/2/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Identity and Access Management Solutions Provider BIO-key Adds Proven Security Sales Leaders in Planned Senior Management Transition

      WALL, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, today announced the appointment of Galen Rodgers, Vice President of Channels, and Chad Carter, VP North America Sales. The appointments are effective today, January 3, and are in anticipation of the planned retirement of Chief Revenue Officer Fred Corsentino. A top-performing technology leader, Galen Rodgers, who will report to Chairman & CEO Michael DePasquale, brings 20+ years of experience in channel program development, marketing strategy, value selling, management, cyber security, proces

      1/3/23 8:01:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Bio-key upgraded by Maxim Group with a new price target

      Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

      3/26/21 7:52:25 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Depasquale Michael W bought $3,900 worth of shares (5,000 units at $0.78), increasing direct ownership by 10% to 53,519 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      6/16/25 8:19:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Chief Executive Officer Depasquale Michael W bought $3,320 worth of shares (4,000 units at $0.83), increasing direct ownership by 9% to 48,519 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      6/4/25 8:30:02 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Chief Executive Officer Depasquale Michael W bought $4,050 worth of shares (5,000 units at $0.81), increasing direct ownership by 13% to 44,519 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      6/3/25 11:27:23 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology

    $BKYI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Depasquale Michael W bought $3,900 worth of shares (5,000 units at $0.78), increasing direct ownership by 10% to 53,519 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      6/16/25 8:19:00 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Chief Executive Officer Depasquale Michael W bought $3,320 worth of shares (4,000 units at $0.83), increasing direct ownership by 9% to 48,519 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      6/4/25 8:30:02 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology
    • Chief Executive Officer Depasquale Michael W bought $4,050 worth of shares (5,000 units at $0.81), increasing direct ownership by 13% to 44,519 units (SEC Form 4)

      4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

      6/3/25 11:27:23 AM ET
      $BKYI
      Computer Software: Prepackaged Software
      Technology